Using technology to improve care for diabetic ketoacidosis in type 1 diabetes patients
A Multi-Disciplinary Technology-Based Care After Hospitalization for Diabetic Ketoacidosis in Patients with Type 1 Diabetes
This study is testing if using continuous glucose monitoring and a supportive healthcare team can help people with type 1 diabetes who are hospitalized for diabetic ketoacidosis recover better and avoid going back to the hospital.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 12 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Trial ID | NCT06471322 on ClinicalTrials.gov |
What this trial studies
This study aims to implement a novel multi-disciplinary approach utilizing continuous glucose monitoring (CGM) technology to enhance glycemic control and reduce readmissions for patients with type 1 diabetes mellitus (T1DM) who are hospitalized due to diabetic ketoacidosis (DKA). The intervention includes a team of healthcare professionals providing immediate post-discharge support and follow-up care. The study will assess the effectiveness of this approach in improving patient outcomes and reducing the high readmission rates associated with DKA. The Cleveland Clinic will facilitate the study, leveraging its resources in endocrinology, diabetes, and metabolism.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with a diagnosis of type 1 diabetes who have been admitted to the hospital for diabetic ketoacidosis and have not previously used continuous glucose monitoring.
Not a fit: Patients with conditions that may limit their ability to participate safely or those with allergies to any components of the continuous glucose monitoring system may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly lower readmission rates and improve glycemic control for patients with type 1 diabetes experiencing diabetic ketoacidosis.
How similar studies have performed: Previous studies utilizing a multi-disciplinary approach in similar contexts have shown success in improving patient outcomes, although this specific application with continuous glucose monitoring is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years old or older * Diagnosis of Type 1 Diabetes * Admitted to the hospital with confirmed diabetic ketoacidosis treated with intravenous insulin infusion * No prior use of continuous glucose monitoring (CGM) * Compatible smart phone with CGM * Allergy to any component of the CGM Exclusion Criteria: * Condition which, in investigator judgement would limit their ability to participate safely
Where this trial is running
Cleveland, Ohio
- The Cleveland Clinic Foundation — Cleveland, Ohio, United States (Recruiting)
Study contacts
- Principal investigator: Zhou Keren, MD — The Cleveland Clinic
- Study coordinator: Kimberly Jenkins
- Email: jenkink@ccf.org
- Phone: 216-316-2889
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.